Skip to main content
Contact Us
Subscribe
E-Edition
68°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
68.02
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
May 02, 2024
Moderna reports Q1 loss, beating sales estimates amidst declining COVID-19 vaccine demand. Cost-saving measures drive optimism for investors. CEO Stéphane Bancel eyes strategic investments. Guidance...
Via
Benzinga
Exposures
COVID-19
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
May 02, 2024
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouraging data from its Phase III gastric cancer treatment trial after...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Moderna (MRNA) Q1 2024 Earnings Call Transcript
May 02, 2024
MRNA earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
MRNA stock results show that Moderna beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
May 02, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,100 Today
May 01, 2024
Via
Benzinga
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
May 02, 2024
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
May 02, 2024
Moderna is forming its first base in over a year. Could shares top a buy point on the company's sales beat?
Via
Investor's Business Daily
Smart Money Is Betting Big In MRNA Options
April 30, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Should You Buy Moderna Before May 12?
April 26, 2024
This ambitious biotech aims to launch 15 products over the coming five years.
Via
The Motley Fool
How Is The Market Feeling About Moderna?
April 25, 2024
Via
Benzinga
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks
May 02, 2024
Current economic tides have turned against Cathie Wood's style of aggressive investing, with three of her picks in particular danger.
Via
InvestorPlace
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
May 01, 2024
These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.
Via
InvestorPlace
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
April 30, 2024
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.
Via
InvestorPlace
mRNA Is Promising A Breakthrough In Fighting Cancer
April 29, 2024
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it...
Via
Benzinga
Exposures
COVID-19
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
April 29, 2024
These stocks aren't bargains.
Via
The Motley Fool
Moderna Options Trading: A Deep Dive into Market Sentiment
April 22, 2024
Via
Benzinga
Moderna Options Trading: A Deep Dive into Market Sentiment
April 17, 2024
Via
Benzinga
2 Stocks Down 30% to Buy Right Now
April 14, 2024
These stocks have plenty of catalysts ahead.
Via
The Motley Fool
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
April 29, 2024
Many technology stocks are soaring, and you may be wondering if they've gotten too expensive.
Via
The Motley Fool
All In on Microsoft Stock: How AI Turned MSFT Into the Hottest Tech Play of 2024
April 27, 2024
Artificial Intelligence is moving Microsoft stock more than even the cloud did, CEO Satya Nadella said, with earnings to prove it.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What's Going On With Pfizer Stock On Thursday?
April 25, 2024
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Moderna Stock Jumps On Collaboration With OpenAI: What's Going On?
April 24, 2024
Moderna began a collaboration with OpenAI in early 2023 with the launch of Moderna's own instance of ChatGPT, called mChat. The company said Wednesday that it has reached more than 80% internal...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
April 23, 2024
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
April 23, 2024
With digital intelligence having the capability of advancing care, these are the medical AI stocks that long-term investors should consider.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
REITs Q1 Earnings Begin On Solid Note
April 23, 2024
Via
Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
April 16, 2024
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost...
Via
Benzinga
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
April 16, 2024
These companies have gotten in on AI early and could emerge as winners.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
April 12, 2024
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.